Author: Lan, Jiaming; Yao, Yanfeng; Deng, Yao; Chen, Hong; Lu, Guangwen; Wang, Wen; Bao, Linlin; Deng, Wei; Wei, Qiang; Gao, George F.; Qin, Chuan; Tan, Wenjie
Title: Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge() Document date: 2015_8_18
ID: q8i2gfut_31
Snippet: To assess the humoral immune response to the rRBD vaccine in rhesus macaques, total anti-MERS-CoV RBD IgG antibody titres were determined by ELISA. Low titres of IgG in serum samples before prime vaccination were detected, possibly due to non-specific responses. IgG titres in the high-dose group increased significantly (p b 0.05) after the first vaccination (Fig. 2a) , and achieved the highest titre of RBDspecific IgG 2 weeks after the second imm.....
Document: To assess the humoral immune response to the rRBD vaccine in rhesus macaques, total anti-MERS-CoV RBD IgG antibody titres were determined by ELISA. Low titres of IgG in serum samples before prime vaccination were detected, possibly due to non-specific responses. IgG titres in the high-dose group increased significantly (p b 0.05) after the first vaccination (Fig. 2a) , and achieved the highest titre of RBDspecific IgG 2 weeks after the second immunisation. Sera IgG titre in the low-dose group increased (p b 0.05) only after the second immunisation, to almost the same level as that of the high-dose group. RBD-specific IgG in the sera of immunised rhesus macaques was preserved for at least 17 weeks without obvious decline. In addition, IgG titre increased rapidly after a subsequent boost. Increased IgG titre was particularly marked in the low-dose group.
Search related documents:
Co phrase search for related documents- antibody titre and high dose: 1, 2, 3
- antibody titre and high titre: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
- antibody titre and IgG titre: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- antibody titre and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- antibody titre and low dose: 1
- antibody titre and low titre: 1, 2, 3
- ELISA determine and immune response: 1, 2, 3
- high dose and IgG titre: 1, 2
- high dose and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- high dose and low dose: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- high dose and low dose group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- high dose and non specific response: 1, 2
- high dose group and immune response: 1, 2
- high dose group and low dose: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- high dose group and low dose group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- high dose group level and low dose: 1, 2, 3
- high dose group level and low dose group: 1, 2, 3
- high titre and IgG titre: 1, 2, 3, 4, 5, 6
- high titre and immune response: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date